Key result
Thrombomodulin shows potential as a blood biomarker for thrombosis risk despite low specificity.
Why the study?
Although thrombomodulin has established diagnostic and prognostic value, its clinical utility is limited by low specificity, prompting a review of its structure, functions, current clinical practice, and potential as a thrombosis risk marker.
Design
Review
Answers are grounded in this paper and cite their sources.
Thrombomodulin serves as a multimodal biomarker with diagnostic and prognostic value for thrombosis risk, though its clinical utility is currently limited by low specificity.
Thrombomodulin (TM) is an active link in coagulation and hemostasis, demonstrating multimodal properties due to its unique structure. TM is expressed mainly on endothelial cells of most vessels, in gestational tissues (placenta and myometrium), in smooth muscle cells of the arteries, and in immune cells. Normally, the TM blood level in healthy individuals does not exceed 10 ng/mL, and usually increases (sometimes decreases) in various abnormal conditions. The role of TM is not limited to the activation of fibrinolysis; it also includes the regulation of inflammation and the immune response, as well as neuro- and angioprotection. The therapeutic potential of recombinant TMs in disseminated intravascular coagulation and preeclampsia is currently under active investigation. In addition, the diagnostic and prognostic value of TM as a blood biomarker across a wide range of diseases is well established. However, the diagnostic utility of TM is still limited by its relatively low specificity. Nevertheless, the experience of using TM in clinical practice indicates the potential for further study of this molecule. This review provides up-to-date information on the structure of TM, its functions, and its current use in medical practice. Also, potential prospects for further study as a marker of thrombosis risk are addressed.
No takes yet. Share an insight, caveat, or question.
Tanashyan et al. (2025) studied this question. Thrombomodulin (TM) exhibits multimodal properties and holds potential as a blood biomarker for thrombosis risk despite its low specificity.
Synapse has enriched 10 related papers. Consider them for comparative context: